<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="en" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">WN69XnL9vyg8DKmDt75KR4Q</article-id>
      <article-id pub-id-type="other">00003</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2000001000003</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(00)07500403</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2000001000003</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Response of blood pressure to maximum exercise in hypertensive patients under different therapeutic programs</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Carreira</surname>
            <given-names>Maria Angela Magalh&#227;es de Queiroz</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ribeiro</surname>
            <given-names>Jamila Costa</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Caldas</surname>
            <given-names>Jos&#233; Ant&#244;nio</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tavares</surname>
            <given-names>Leandro Reis</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nani</surname>
            <given-names>Eduardo</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="state">Rio de Janeiro</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal Fluminense</institution>
        <institution content-type="orgdiv1">Hospital Universit&#225;rio Ant&#244;nio Pedro </institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>10</month>
        <year>2000</year>
      </pub-date>
      <volume>75</volume>
      <issue>4</issue>
      <fpage>285</fpage>
      <lpage>288</lpage>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>OBJECTIVE: To evaluate the behavior of blood pressure during exercise in patients with hypertension controlled by frontline antihypertension drugs. METHODS: From 979ergometric tests we retrospectively selected 49 hipertensive patients (19 males). The age was 53&#177;12 years old and normal range rest arterial pressure (&lt;=140/90 mmHg) all on pharmacological monotherapy. There were 12 on beta blockers; 14 on calcium antagonists, 13 on diuretics and 10 on angiotensin converting enzyme inhibitor. Abnormal exercise behhavior of blood pressure was diagnosed if anyone of the following criteria was detected: peak systolic pressure above 220 mmHg, raising of systolic pressure  &gt; or =  10 mmHg/MET; or increase of diastolic pressure greater than 15 mmHg. RESULTS: Physiologic response of arterial blood pressure occurred in 50% of patients on beta blockers, the best one (p&lt;0.05), in 36% and 31% on calcium antagonists and on diuretics, respectively, and in 20% on angiotensin converting enzyme inhibitor, the later the leastr one (p&lt;0.05). CONCLUSION: Beta-blockers were more effective than calcium antagonists, diuretics and angiotensin-converting enzyme inhibitors in controlling blood pressure during exercise, and angiotensin converting enzyme inhibitors the least effective drugs.</p>
      </abstract>
      <kwd-group xml:lang="en" kwd-group-type="author-generated">
        <kwd>stress test</kwd>
        <kwd>arterial hypertension</kwd>
        <kwd>antihypertension therapy</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>25</day>
        <month>10</month>
        <year>2000</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>Original</bold>
      <bold>Article</bold>
    </p>
    <p>
      <bold>Response of Blood Pressure to Maximum Exercise in Hypertensive Patients under Different Therapeutic Programs</bold>
    </p>
    <p>Maria Angela Magalh&#227;es de Queiroz Carreira, Jamila Costa Ribeiro, Jos&#233; Ant&#244;nio Caldas, Leandro Reis Tavares, Eduardo Nani </p>
    <p>
      <bold>Niter&#243;i, RJ - Brazil </bold>
    </p>
    <p><bold><italic>OBJECTIVE: </italic></bold>To evaluate the behavior of blood pressure during exercise in patients with hypertension controlled by frontline antihypertension drugs. </p>
    <p><bold><italic>METHODS: </italic></bold>From 979ergometric tests we retrospectively selected 49 hipertensive patients (19 males). The age was 53&#177;12 years old and normal range rest arterial pressure (&#163; <italic>140/90 mmHg) all on pharmacological monotherapy. There were 12 on beta blockers; 14 on calcium antagonists, 13 on diuretics and 10 on angiotensin converting enzyme inhibitor. Abnormal exercise behhavior of blood pressure was diagnosed if anyone of the following criteria was detected: peak systolic pressure above 220 mmHg, raising of systolic pressure </italic>&#179; 10 mmHg/MET; or increase of diastolic pressure greater than 15 mmHg. </p>
    <p><bold><italic>RESULTS: </italic></bold>Physiologic response of arterial blood pressure occurred in 50% of patients on beta blockers, the best one (p&lt;0.05), in 36% and 31% on calcium antagonists and on diuretics, respectively, and in 20% on angiotensin converting enzyme inhibitor, the later the leastr one (p&lt;0.05). </p>
    <p><bold><italic>CONCLUSION: </italic></bold>Beta-blockers were more effective than calcium antagonists, diuretics and angiotensin-converting enzyme inhibitors in controlling blood pressure during exercise, and angiotensin converting enzyme inhibitors the least effective drugs.</p>
    <p><bold>Key words: </bold>stress test, arterial hypertension, antihypertension therapy </p>
    <p>The purpose of treatment of blood pressure is currently to reduce morbidity and mortality by the least invasive manner possible, which may be achieved either by changes in lifestyle, such as weight loss, exercising, reduction in sodium and alcohol intake, or by association with a pharmacological treatment <sup>1-3</sup>. </p>
    <p>Moderate exercise, such as walking, biking, and swimming, done regularly, has been shown to be an important ally in the reduction of blood pressure levels in hypertensive persons <sup>3</sup>. </p>
    <p>Ambulatory blood pressure monitoring in hypertensive patients, has showed higher the percentage of measurements above the normal values within the 24 hours (pressor load) as a result, for instance, of exercise, work, and the act of awaking greater the damage to the target organ or the incidence of medical events associated with hypertension <sup>4</sup>. It is therefore expected that antihypertensive drugs should be able to control blood pressure not only at rest, but also during physical activity. </p>
    <p>Because a physical activity program is part of the treatment, the behavior of blood pressure during exercise provides indispensable data for the therapeutic evaluation of hypertensive individuals <sup>5,6</sup>. It is more difficult to obtain reliable measurements by means of ambulatory blood pressure monitoring during the patients' activity, which makes evaluation by means of a exercise test necessary <sup>4,7</sup>. </p>
    <p>The objective of our study was to evaluate whether any differences existed among the various groups of frontline drugs for the treatment of hypertension, regarding their capacity to control blood pressure during physical activity. </p>
    <p>Methods </p>
    <p>Nine hundred and seventy-nine exercise tests performed at the Treadmill Stress Test Service of <italic>Hospital Universit&#225;rio Ant&#244;nio Pedro</italic> between January 1996 and September 1997 were retrospectively evaluated, and we selected that belonged to patients with primary hypertension under regular pharmacological treatment with frontline antihypertension drugs, with blood pressure at rest below or equal to 140/90mmHg when being tested, and no other cardiovascular disease. Forty-nine patients (19 males) with mean ages (&#177;SD) of 53&#177;12 years met the selection criteria. Twenty-four percent of patients (n=12) were using antihypertension medication belonging to the beta-blocker<strike>s </strike>group, 29% (n=14) used calcium antagonists, 27% (n=13) diuretics, and 20% of the patients (n=10) were using medication belonging to the group of angiotensin-converting enzyme inhibitors (<xref ref-type="table" rid="table1">Table I</xref>). Mean systolic and diastolic blood pressure at rest and mean ages were similar in all groups (<xref ref-type="table" rid="table2">Table II</xref>). The behavior of blood pressure under stress was considered abnormal, if one of the following three criteria <sup>8 </sup>existed: systolic pressure on the peak of stress higher than 220mmHg, variation in diastolic pressure under stress higher than 15mmHg, or variation of systolic pressure/MET (metabolic equivalent) higher than or equal to 10mmHg. All tests were performed on a treadmill, following the Bruce or modified Bruce protocols, and symptom-limited. Blood pressure was measured in a noninvasive manner by means of a mercury-column device (Tycos, USA), whereby the blood pressure at rest was obtained on the left arm, the patient being in an orthostatic position on the treadmill. </p>
    <table-wrap id="table1">
      <graphic xlink:href="1678-4170-abc-75-04-0285-00003-gt01.jpg"/></table-wrap>
    <table-wrap id="table2">
      <graphic xlink:href="1678-4170-abc-75-04-0285-00003-gt02.jpg"/></table-wrap>
    <p>Statistical analysis was based on ANOVA. Once significance was reached, <italic>post-hoc</italic> analysis was made using Student's <italic>t</italic> test with the Bonferroni correction for variables having a normal distribution (age, systolic blood pressure). For variables that did not have normal distribution (diastolic blood pressure), the Mann-Whitney test was used, and the Chi-square test was used to compare proportions (tensional response). Values of p&lt;0.05 were considered statistically significant. </p>
    <p>Results </p>
    <p>The groups were similar in age and systolic and diastolic blood pressure at rest (<xref ref-type="table" rid="table2">Table II</xref>). The mean systolic pressure upon maximum exercise was lower in the patients using beta-blockers than in the other groups (p&lt;0.05), the values being the following: 179&#177;20mmHg for the beta-blockers, 198&#177;32mmHg for the calcium antagonists, 204&#177;22mmHg for the diuretics and 203&#177;17mmHg for the angiotensin-converting enzyme inhibitors. No difference occurred among the four groups regarding the mean values of diastolic pressure upon maximum exercise (p&gt;0.05) (<xref ref-type="table" rid="table2">Table II</xref>). </p>
    <p>No significant difference existed in the blood pressure response to exercise between the groups of patients using diuretic drugs and those using calcium antagonists. Thirty-one percent of the patients in the group with diuretics and 36% of the patients in the group with calcium antagonists showed a physiological response in blood pressure (p=0.40). In the group of patients using beta-blockers, 50% showed a physiological response of blood pressure to exercise, this difference being statistically significant as compared with that in the other three groups (p&lt;0.05). In the group of patients using angiotensin-converting enzyme inhibitors, we found that only 20% had a physiological response of blood pressure to exercise, which was significantly lower as compared with that in the other drug groups (p&lt;0.05) (<xref ref-type="fig" rid="figure1">Fig. 1</xref>). </p>
    <fig id="figure1">
      <graphic xlink:href="1678-4170-abc-75-04-0285-00003-gf01.jpg"/></fig>
    <p>Discussion </p>
    <p>Some authors have shown that the use of the angiotensin-converting enzyme inhibitor captopril does not reduce blood pressure under maximum stress <sup>9,10</sup>. Manhem et al.<sup>10</sup> studied the effect of captopril on catecholamines, renin activity, angiotensin II, and aldosterone in plasma during physical exercise in hypertensive patients and concluded that, despite a pronounced decrease in angiotensin II formation, captopril did not change the response of blood pressure to exercise. In our study, the group of angiotensin-converting enzyme inhibitors was the least effective one in controlling blood pressure under stress. However, we noticed that 70% of patients were using captopril, so it is possible that different kinds of responses might occur with other angiotensin-converting enzyme inhibitors, as in the study of Kinugawa et al. <sup>11 </sup>with the angiotensin-converting enzyme inhibitor alacepril, where a decrease in blood pressure under stress was observed. </p>
    <p>Kostis et al. <sup>9</sup> evaluated the different effects of captopril and nadolol during exercise and showed that both drugs reduce the increase of diastolic blood pressure during exercise. However, although the systolic blood pressure at rest was lower after captopril use, under stress it was lower with nadolol than with captopril. These data are consistent with those obtained in our study, where a significantly lower systolic blood pressure under exercise was observed in the patients treated with beta-blockers, and diastolic blood pressure was similar in all four groups. These different responses to exercise seem to be related to the antihypertensive mechanism of action of each drug. The decrease in blood pressure after angiotensin-converting enzyme inhibitor use is associated with the decrease in peripheral vessel resistance, without any interference in cardiac output <sup>9 </sup>whereas the use of beta-blockers reduces blood pressure by reducing cardiac output <sup>12</sup>. </p>
    <p>In our study, no significant difference occurred in blood pressure control during exercise between the group using calcium antagonists and the group using diuretics. The calcium antagonists reduce blood pressure through direct vasodilative action on the smooth vascular muscles, with a reduction in peripheral vascular resistance as a consequence <sup>13,14</sup>. However, they constitute a heterogeneous group of drugs, because phenylalkilamines have a negative effect on chronotropism and inotropism, whereas dihydropyridines do not significantly alter cardiac output<sup>15</sup>. Roberts et al. <sup>16</sup> did not find any difference in blood pressure at rest or after exercise between captopril and nifedipine. Yet, our results showed a better control of blood pressure in the group using calcium antagonists than in the group using angiotensin-converting enzyme inhibitors. This may be a consequence of the fact that 65% of the patients in the calcium antagonist group were using phenylalkilamines therefore possibly reflecting a cardiac output decrease associated with a decrease in peripheral vascular resistance in a significant number of patients. </p>
    <p>Thiazide diuretics reduce blood pressure at the beginning of treatment through the reduction of volemia and, consequently, of cardiac output. However, after 4 to 6 weeks, their mechanism of action involves mainly the decrease in peripheral vascular resistance <sup>17</sup>. In our study, the time of treatment was not determined, so variations might occur in the diuretics' mechanism of action. </p>
    <p>Although the time that elapsed between drug intake and performance of the exercise test was not properly controlled, all patients included in this study had a controlled blood pressure at rest, which allows us to assume that adequate use of anti-hypertension medication occurred. </p>
    <p>Blood pressure measurements, mainly of diastolic pressure, during exercise tests may be difficult because of the noise coming from the treadmill and of muscle movement. Nevertheless, Pickering et al. <sup>18</sup> found a close correlation between systolic and diastolic blood pressure for a certain heart rate obtained by ambulatory blood pressure monitoring and those obtained during exercise testing. It is worth pointing out that several authors have evaluated systolic and diastolic pressures under exercise through indirect measurements, in different clinical and therapeutic situations, thus undeniably contributing to a better understanding of the mechanisms involving the behavior of blood pressure during exercise <sup>9-12, 14,15,19,20</sup>. </p>
    <p>The evaluation of hemodynamic responses of hypertensive patients during a stress test can provide important data for the therapeutic choice, considering that the purpose of the treatment is adequate control of blood pressure, not only at rest, but also during daily activities and exercise. Our data suggest that, in hypertensive patients with an excessive response of blood pressure to exercise, the use of beta-blockers may provide greater benefits in the control of blood pressure than the use of angiotensin-converting enzyme inhibitors. </p>
    <p>Acknowledgements </p>
    <p>To Prof. Antonio Cl&#225;udio Lucas da N&#243;brega for the collaboration and suggestions. </p>
    <p>Hospital Universit&#225;rio Ant&#244;nio Pedro - Universidade Federal Fluminense </p>
    <p> Mailing address: Maria Angela M. Queiroz Carreira &#190; Rua Soldado Jo&#227;o de Deus Araujo, 54 &#190; 22765-380 - Rio de Janeiro, RJ </p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Mancia G, Fratolla A, Gropelli A, et al. Redu&#231;&#259;o da press&#259;o arterial e dano aos &#243;rg&#259;os alvo na hipertens&#259;o. J Hypertension 1994; 12: S35-S42. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Redu&#231;&#227;o da press&#227;o arterial e dano aos &#243;rg&#227;os alvo na hipertens&#227;o</article-title>
          <source>J Hypertension</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>S35</fpage>
          <lpage>S42</lpage>
          <volume>12</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Mancia</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Fratolla</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gropelli</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. The Sixth Report of the Joint National Committee on prevencion, detection and treatment of high blood pressure. Arch Inter Med 1997; 157: 2413-45. </mixed-citation>
        <element-citation publication-type="journal">
          <source>Arch Inter Med</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>2413</fpage>
          <lpage>45</lpage>
          <volume>157</volume>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. III Consenso Brasileiro de Hipertens&#259;o arterial. Rev Soc Bras Hipert 1998; 1(supl): 1-38. </mixed-citation>
        <element-citation publication-type="journal">
          <source>Rev Soc Bras Hipert</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>1</fpage>
          <lpage>38</lpage>
          <volume>1</volume>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Oigman W, Neves MFT. Hipertens&#259;o arterial. Rev Bras Med 1998; 54: 97-111. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Hipertens&#227;o arterial</article-title>
          <source>Rev Bras Med</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>97</fpage>
          <lpage>111</lpage>
          <volume>54</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Oigman</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Neves</surname>
              <given-names>MFT</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Crit&#233;rios para solicita&#231;&#259;o de exames complementares do aparelho cardiovascular. Arq Bras Cardiol 1997; 68: I-IX. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Crit&#233;rios para solicita&#231;&#227;o de exames complementares do aparelho cardiovascular</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>I</fpage>
          <lpage>IX</lpage>
          <volume>68</volume>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Jardim PCBY, Souza ALL. Determina&#231;&#259;o da press&#259;o arterial: hist&#243;ria, m&#233;todos e limita&#231;&#337;es. HiperAtivo 1997; 4: 6-11. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Determina&#231;&#227;o da press&#227;o arterial: hist&#243;ria, m&#233;todos e limita&#231;&#245;es</article-title>
          <source>HiperAtivo</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>6</fpage>
          <lpage>11</lpage>
          <volume>4</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Jardim</surname>
              <given-names>PCBY</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>ALL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Rudd P, Hagar W. Hypertension: mechanisms, diagnosis and therapy. In: Topol EJ. Textbook of Cardiovascular Medicine. Philadelphia: Lippincott-Raven, 1998: 109-44. </mixed-citation>
        <element-citation publication-type="book">
          <source>Textbook of Cardiovascular Medicine</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>109</fpage>
          <lpage>44</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Rudd</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hagar</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Topol</surname>
              <given-names>EJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Lima EG, Marsaro EA. Ergometria e hipertens&#259;o arterial. In: Amodeo C, Lima EG, Vasquez EC. Hipertens&#259;o Arterial. S&#259;o Paulo: Sarvier, 1997: 187-90. </mixed-citation>
        <element-citation publication-type="book">
          <source>Hipertens&#227;o Arterial</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>187</fpage>
          <lpage>90</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Lima</surname>
              <given-names>EG</given-names>
            </name>
            <name>
              <surname>Marsaro</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Amodeo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>EG</given-names>
            </name>
            <name>
              <surname>Vasquez</surname>
              <given-names>EC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Kostis JB, Shindler DM, Moreyra AE, et al. Differential exercise effects of captopril and nadolol in patients with essential hypertension. J Vasc Disease 1992; August: 647-52. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Differential exercise effects of captopril and nadolol in patients with essential hypertension</article-title>
          <source>J Vasc Disease</source>
          <date>
            <year>1992</year>
          </date>
          <fpage>647</fpage>
          <lpage>52</lpage>
          <volume>August</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kostis</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Shindler</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Moreyra</surname>
              <given-names>AE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Manhem P, Bramnert M, Hulth&#233;n UL, H&#246;kfelt . The effect of captopril on catecholamines, renin activity, angiotensin II and aldosterone in plasma during physical exercise in hypertensive patients. Eur J Clin Invest 1981; 11: 389-95. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The effect of captopril on catecholamines, renin activity, angiotensin II and aldosterone in plasma during physical exercise in hypertensive patients</article-title>
          <source>Eur J Clin Invest</source>
          <date>
            <year>1981</year>
          </date>
          <fpage>389</fpage>
          <lpage>95</lpage>
          <volume>11</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Manhem</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bramnert</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hulth&#233;n</surname>
              <given-names>UL</given-names>
            </name>
            <name>
              <surname>H&#246;kfelt</surname>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Kinugawa T, Kitamura H, Ogino K. Effect of alacepril on blood pressure and neurohumoral factors at rest and during dynamic exercise in patients with essential hypertension. Br J Clin Pharmac 1992; 34: 366-9. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effect of alacepril on blood pressure and neurohumoral factors at rest and during dynamic exercise in patients with essential hypertension</article-title>
          <source>Br J Clin Pharmac</source>
          <date>
            <year>1992</year>
          </date>
          <fpage>366</fpage>
          <lpage>9</lpage>
          <volume>34</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kinugawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kitamura</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ogino</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Botura AL, Russo AK, Barros Neto TL, et al. Efeito do propranolol e metoprolol nas respostas cardio-respirat&#243;rias e metab&#243;licas ao exerc&#237;cio. Arq Bras Cardiol 1991; 57: 459-64. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Efeito do propranolol e metoprolol nas respostas cardio-respirat&#243;rias e metab&#243;licas ao exerc&#237;cio</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>1991</year>
          </date>
          <fpage>459</fpage>
          <lpage>64</lpage>
          <volume>57</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Botura</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Russo</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Barros</surname>
              <given-names>Neto TL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Ferruci A, Marcheselli A, Strano A, et al. Perfis da press&#259;o arterial de 24 horas em pacientes portadores de hipertens&#259;o tratados com amlodipina ou nifedipina GITS. Clin Drug Invest 1997; 13(suppl 1): 67-72. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Perfis da press&#227;o arterial de 24 horas em pacientes portadores de hipertens&#227;o tratados com amlodipina ou nifedipina GITS</article-title>
          <source>Clin Drug Invest</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>67</fpage>
          <lpage>72</lpage>
          <volume>13</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ferruci</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Marcheselli</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Strano</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Grossman E, Messerli FH, Oren S, et al. Disparate cardiovascular response to stress tests during isradipina and fosinopril therapy. Am J Cardiol 1993; 72: 574-9. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Disparate cardiovascular response to stress tests during isradipina and fosinopril therapy</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>574</fpage>
          <lpage>9</lpage>
          <volume>72</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Grossman</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Messerli</surname>
              <given-names>FH</given-names>
            </name>
            <name>
              <surname>Oren</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Schmieder RE, Bahr M, Langewitz W. Efficacy of four antihipertensive drugs (clonidine, enalapril, nitrendipine, oxprenolol) on stress blood pressure. Am J Cardiol 1989; 63: 1333-8. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Efficacy of four antihipertensive drugs (clonidine, enalapril, nitrendipine, oxprenolol) on stress blood pressure</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>1989</year>
          </date>
          <fpage>1333</fpage>
          <lpage>8</lpage>
          <volume>63</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Schmieder</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Bahr</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Langewitz</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Roberts DH, Tsao Y, Linge K. Double-blind comparison of captopril with nifedipine in hypertension complicated by intermittent claudication. J Vasc Disease 1992; September: 748-56. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Double-blind comparison of captopril with nifedipine in hypertension complicated by intermittent claudication</article-title>
          <source>J Vasc Disease</source>
          <date>
            <year>1992</year>
          </date>
          <fpage>748</fpage>
          <lpage>56</lpage>
          <volume>September</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Roberts</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Tsao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Linge</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Brand&#259;o AP, Brand&#259;o AA, Pozzan R. Farmacologia cl&#237;nica de diur&#233;ticos e bloqueadores alfa adren&#233;rgicos. HiperAtivo, 1995; 2: 16-23. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Farmacologia cl&#237;nica de diur&#233;ticos e bloqueadores alfa adren&#233;rgicos</article-title>
          <source>HiperAtivo</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>16</fpage>
          <lpage>23</lpage>
          <volume>2</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Brand&#227;o</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Pozzan</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Pickering TG, Harshfield GA, Kleinert HD, et al. Blood pressure during normal daily activities, sleep and exercise. JAMA 1982; 247: 992-8. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Blood pressure during normal daily activities, sleep and exercise</article-title>
          <source>JAMA</source>
          <date>
            <year>1982</year>
          </date>
          <fpage>992</fpage>
          <lpage>8</lpage>
          <volume>247</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pickering</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Harshfield</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Kleinert</surname>
              <given-names>HD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Palatini P, Bongiovi S, Mario L, et al. Effects of ACE inhibition on endurance exercise haemodynamics in trained subjects with mild hypertension. Eur J Clin Pharmacol 1995; 48: 435-9. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effects of ACE inhibition on endurance exercise haemodynamics in trained subjects with mild hypertension</article-title>
          <source>Eur J Clin Pharmacol</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>435</fpage>
          <lpage>9</lpage>
          <volume>48</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Palatini</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bongiovi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mario</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Handa K, Sasaki J, Tanaka H, et al. Effects of captopril on opioid peptides during exercise and quality of life in normal subjects. Am Heart J 1991; 122: 1389-94. </mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effects of captopril on opioid peptides during exercise and quality of life in normal subjects</article-title>
          <source>Am Heart J</source>
          <date>
            <year>1991</year>
          </date>
          <fpage>1389</fpage>
          <lpage>94</lpage>
          <volume>122</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Handa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sasaki</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
